TCL Archive Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director. By Cancer History Project September 16, 2005
TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. By Cancer History Project September 16, 2005
TCL Archive Three cancer centers joined the Multiple Myeloma Research Consortium. By Cancer History Project September 16, 2005
TCL Archive House committee asks GAO to investigate Klausner-era NCI contract with Harvard University. By Cancer History Project September 9, 2005
TCL Archive Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head. By Cancer History Project September 9, 2005
TCL Archive Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees. By Cancer History Project September 9, 2005
TCL Archive Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting. By Cancer History Project September 9, 2005
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds By Cancer History Project August 26, 2005
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
